LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 2510 | 5013 | 0.5007 | 0.3238 |
MDA-MB-231 | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4180 | 5013 | 0.8339 | 0.7750 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 5080 | 5013 | 1.0134 | 1.0181 |
MDA-MB-231 | SU11274 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4987 | 5013 | 0.9947 | 0.9928 |
MDA-MB-231 | Fedratinib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4327 | 5013 | 0.8632 | 0.8147 |
MDA-MB-231 | TGX221 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4311 | 5013 | 0.8599 | 0.8103 |
MDA-MB-231 | Torin1 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1790 | 5013 | 0.3572 | 0.1294 |
MDA-MB-231 | Torin2 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1600 | 5013 | 0.3192 | 0.0780 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1440 | 5013 | 0.2874 | 0.0348 |
MDA-MB-231 | Trametinib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1731 | 5013 | 0.3453 | 0.1133 |
MDA-MB-231 | TWS119 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 3957 | 5013 | 0.7893 | 0.7147 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4731 | 5013 | 0.9438 | 0.9239 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1384 | 5013 | 0.2762 | 0.0197 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1295 | 5013 | 0.2584 | -0.0043 |
MDA-MB-231 | WYE-125132 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 1996 | 5013 | 0.3983 | 0.1850 |
MDA-MB-231 | WZ3105 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 832 | 5013 | 0.1660 | -0.1296 |
MDA-MB-231 | XMD11-50 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 2613 | 5013 | 0.5213 | 0.3517 |
MDA-MB-231 | Y39983 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4006 | 5013 | 0.7991 | 0.7279 |
MDA-MB-231 | YM 201636 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4030 | 5013 | 0.8039 | 0.7344 |
MDA-MB-231 | ZSTK474 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 3595 | 5013 | 0.7171 | 0.6169 |
MDA-MB-231 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 2811 | 5013 | 0.5608 | 0.4052 |
MDA-MB-231 | Sigma A6730 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4571 | 5013 | 0.9118 | 0.8806 |
MDA-MB-231 | Alvocidib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 734 | 5013 | 0.1465 | -0.1560 |
MDA-MB-231 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 613 | 5013 | 0.1223 | -0.1888 |
MDA-MB-231 | AZD 5438 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 771 | 5013 | 0.1538 | -0.1461 |